Takeda Pharmaceutical (TAK) Amortization - Intangibles (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Amortization - Intangibles of -$824.5 million for Q1 2026, up 9.24% year-over-year from -$754.7 million in Q1 2025, and up 7.04% quarter-over-quarter from -$887.0 million in Q4 2025.
Takeda Pharmaceutical (TAK) Amortization - Intangibles (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Amortization - Intangibles history runs 8 years deep, the most recent figure standing at -$824.5 million for Q1 2026.
- In Q1 2026, Amortization - Intangibles rose 9.24% year-over-year to -$824.5 million; the TTM figure through Mar 2026 stood at -$5.5 billion (changed 0.12% YoY), while the FY2026 annual figure was $4.2 billion, changed 0.33% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at -$824.5 million, up from -$887.0 million in the prior quarter.
- The five-year high for Amortization - Intangibles was -$810.5 million in Q4 2022, with the low at -$2.8 billion in Q3 2025.
- The 5-year median for Amortization - Intangibles is -$933.3 million (2023), against an average of -$1.4 billion.
- The sharpest annual moves came in 2023 and 2026: Amortization - Intangibles dropped 11.69% in 2023, then rose 9.24% in 2026.
- Takeda Pharmaceutical's Amortization - Intangibles stood at -$810.5 million in 2022, then decreased by 11.69% to -$905.2 million in 2023, then grew by 0.81% to -$897.9 million in 2024, then gained by 1.21% to -$887.0 million in 2025, then grew by 7.04% to -$824.5 million in 2026.
- Business Quant data shows TAK's Amortization - Intangibles at -$824.5 million in Q1 2026, -$887.0 million in Q4 2025, and -$2.8 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -824.49 Mn |
| Dec 31, 2025 | -886.96 Mn |
| Sep 30, 2025 | -2.79 Bn |
| Jun 30, 2025 | -959.95 Mn |
| Mar 31, 2025 | -908.47 Mn |
| Dec 31, 2024 | -897.87 Mn |
| Sep 30, 2024 | -2.76 Bn |
| Jun 30, 2024 | -892.28 Mn |
| Mar 31, 2024 | -935.25 Mn |
| Dec 31, 2023 | -905.19 Mn |
| Sep 30, 2023 | -2.68 Bn |
| Jun 30, 2023 | -953.71 Mn |
| Mar 31, 2023 | -931.39 Mn |
| Dec 31, 2022 | -810.47 Mn |
| Sep 30, 2022 | -2.68 Bn |
| Jun 30, 2022 | -957.27 Mn |
| Sep 30, 2020 | -2.92 Bn |
| Mar 31, 2020 | -969.88 Mn |
| Sep 30, 2019 | -0.95 |
| Mar 31, 2019 | -0.22 |